Risk Management Approaches of Unaffected BRCA1/2 Carriers Vary Widely

A systematic review published in the European Journal of Surgical Oncology reveals significant global variation in how women with BRCA1/2 genetic mutations manage their breast cancer risk. While some opt for prophylactic mastectomy, many others prefer intensive surveillance, reflecting diverse personal and medical decision-making.
For women who are unaffected carriers of BRCA1 / 2 pathogenic variants, breast cancer risk management approaches have varied widely, according to research published in the European Journal of Surgical Oncology .
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in